Food, drugs, devices › Codman & Shurtleff, Inc.
Device recall: NEUROPATH 6Fx90 GUIDING CATH MPC Product Code: GMC60900000 Intended for use in the coronary, peripheral, and neurovascul
FDA enforcement event 64158 is a device recall by Codman & Shurtleff, Inc. of Raynham, MA, initiated 11 Jan 2013 and classified Class II, with 24 product records.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 90% of the 1,236 device enforcement events initiated in 2013 carry the same class.
Status: Terminated, terminated 10 Aug 2015. Initiation: voluntary: firm initiated. Codman & Shurtleff, Inc. has 11 enforcement events on this register, with a median of 2 product records per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Codman & Shurtleff, Inc., Raynham, MA.
Reason for recall
"Sterility of device may be compromised due to lack of package integrity"
Distribution
"Worldwide Distribution - USA (nationwide) and Internationally to Austria, Belgium, Canada, Chile, Costa, Rica, Czech Republic, Denmark, France, Germany, Great Britian/UK, Ireland, Italy, Lithuania,…"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-0842-2013 | NEUROPATH 6Fx90 GUIDING CATH MPC Product Code: GMC60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 867 units | Class II | Terminated | 27 Feb 2013 |
| Z-0843-2013 | NEUROPATH 5Fx90 GUIDING CATH S2 Product Code: GSM50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 19 units | Class II | Terminated | 27 Feb 2013 |
| Z-0844-2013 | NEUROPATH 6Fx90 GUIDING CATH HH Product Code: GHH60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 56 units | Class II | Terminated | 27 Feb 2013 |
| Z-0845-2013 | NEUROPATH 5Fx100 GUIDING CATH HH Product Code: GHH51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 50 units | Class II | Terminated | 27 Feb 2013 |
| Z-0846-2013 | NEUROPATH 5Fx100 GUIDING CATH HH Product Code: GMC51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 234 units | Class II | Terminated | 27 Feb 2013 |
| Z-0847-2013 | NEUROPATH 6Fx100 GUIDING CATH MPD Product Code: GMD60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 867 units | Class II | Terminated | 27 Feb 2013 |
| Z-0848-2013 | NEUROPATH 5Fx100 GUIDING CATH MP Product Code:GMD51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 273 units | Class II | Terminated | 27 Feb 2013 |
| Z-0849-2013 | NEUROPATH 6Fx100 GUIDING CATH ST Product Code: GST61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 266 units | Class II | Terminated | 27 Feb 2013 |
| Z-0850-2013 | NEUROPATH 5Fx100 GUIDING CATH S2 Product Code: GSM51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 32 units | Class II | Terminated | 27 Feb 2013 |
| Z-0851-2013 | NEUROPATH 6Fx100 GUIDING CATH MC Product Code: GCB61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 34 units | Class II | Terminated | 27 Feb 2013 |
| Z-0852-2013 | NEUROPATH 6Fx100 GUIDING CATH S2 Product Code: GSM61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 129 units | Class II | Terminated | 27 Feb 2013 |
| Z-0853-2013 | NEUROPATH 5Fx100 GUIDING CATH MC Product Code: GCB51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 5 units | Class II | Terminated | 27 Feb 2013 |
| Z-0854-2013 | NEUROPATH 5Fx90 GUIDING CATH MCV Product Code: GCB50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 5 units | Class II | Terminated | 27 Feb 2013 |
| Z-0855-2013 | NEUROPATH 5Fx90 GUIDING CATH MPC Product Code: GMC50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 202 units | Class II | Terminated | 27 Feb 2013 |
| Z-0856-2013 | NEUROPATH 6Fx100 GUIDING CATH MP Product Code: GMD61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 1548 units | Class II | Terminated | 27 Feb 2013 |
| Z-0857-2013 | NEUROPATH 5Fx90 GUIDING CATH MPD Product Code: GMD50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 202 units | Class II | Terminated | 27 Feb 2013 |
| Z-0858-2013 | NEUROPATH 5Fx100 GUIDING CATH ST Product Code: GST51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 46 units | Class II | Terminated | 27 Feb 2013 |
| Z-0859-2013 | NEUROPATH 5Fx90 GUIDING CATH ST Product Code: GST50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 46 units | Class II | Terminated | 27 Feb 2013 |
| Z-0860-2013 | NEUROPATH 6Fx90 GUIDING CATH ST Product Code: GST60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 268 units | Class II | Terminated | 27 Feb 2013 |
| Z-0861-2013 | NEUROPATH 5Fx90 GUIDING CATH HH Product Code: GHH50900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 141 units | Class II | Terminated | 27 Feb 2013 |
| Z-0862-2013 | NEUROPATH 6Fx90 GUIDING CATH MCV Product Code: GCB60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 10 units | Class II | Terminated | 27 Feb 2013 |
| Z-0863-2013 | NEUROPATH 6Fx90 GUIDING CATH S2 Product Code: GSM60900000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 64 units | Class II | Terminated | 27 Feb 2013 |
| Z-0864-2013 | NEUROPATH 6Fx100 GUIDING CATH HH Product Code: GHH61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 25 | Class II | Terminated | 27 Feb 2013 |
| Z-0865-2013 | NEUROPATH 6Fx100 GUIDING CATH MP Product Code: GMC61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices | 522 units | Class II | Terminated | 27 Feb 2013 |
Context
Other enforcement events for Codman & Shurtleff, Inc.
All 11 events for Codman & Shurtleff, Inc.
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "Sterility of device may be compromised due to lack of package integrity"
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Worldwide Distribution - USA (nationwide) and Internationally to Austria, Belgium, Canada, Chile, Costa, Rica, Czech Republic, Denmark, France, Germany, Great Britian/UK, Ireland, Italy, Lithuania,…"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 10 Aug 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.